Key result
Luteolin, a TXNIP degrader, significantly inhibited HSV-1 viral replication and improved pathological conditions in infected mice by restoring MAVS-mediated antiviral signaling.
Why the study?
Thioredoxin-interacting protein (TXNIP) regulates oxidative stress, inflammation, and glucose metabolism, but its role in viral infection and potential as a therapeutic target remained to be investigated.
TXNIP acts as a critical negative regulator of host antiviral immunity by disrupting MAVS aggregation, making it a promising therapeutic target for viral infections.
Answers are grounded in this paper and cite their sources.
Supports TXNIP inhibition as antiviral strategy in vitro; leaves open clinical translation for HSV-1.
Thioredoxin-interacting protein (TXNIP) is a multifunctional regulator involved in oxidative stress, inflammation, and glucose metabolism. In this study, we investigated the role of TXNIP in viral infection and its potential as a therapeutic target. Our findings reveal that HSV-1 infection induces TXNIP upregulation, and elevated TXNIP levels promote viral replication by inhibiting MAVS aggregation. This inhibition disrupts the TBK1/IRF3 signaling pathway, leading to reduced interferon-beta (IFN-β) production and impaired antiviral immunity. Conversely, TXNIP knockout significantly suppresses HSV-1 infection. Furthermore, we utilized Luteolin, a TXNIP degrader previously reported by our group, which restores MAVS aggregation and enhances antiviral responses, demonstrating potent antiviral effects both in vitro and in vivo. Notably, this mechanism was also validated in dengue virus (DENV2) infection, suggesting a broader role for TXNIP in immune regulation. These findings establish TXNIP as a critical modulator of viral infection and highlight TXNIP degraders as promising candidates for antiviral therapy.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied HSV-1 infection (n=20). Luteolin vs. HSV-1 infected (untreated) was evaluated on Viral replication and pathological severity. Luteolin, a TXNIP degrader, significantly inhibited HSV-1 viral replication and improved pathological conditions in infected mice by restoring MAVS-mediated antiviral signaling.
Synapse has enriched 10 related papers. Consider them for comparative context: